Previously, we showed that the protease-resistant CNP analog BMN-111 increases bone growth in a mouse model of ACH, in which tyrosine 367 is changed to a cysteine (Fgfr3Y367C/+), resulting in constitutive activation of FGFR3 (32, 44). The gene discussed is CNP; the disease is achondroplasia.